558 related articles for article (PubMed ID: 28161854)
21. To DGP-IgG or not? a comparison of TTG-IgA and DGP-IgG.
Pacheco MC; Lee D; Dickerson J
Clin Chim Acta; 2022 Jun; 531():382-385. PubMed ID: 35550816
[TBL] [Abstract][Full Text] [Related]
22. Clinical utility of serologic testing for celiac disease in ontario: an evidence-based analysis.
Medical Advisory Secretariat
Ont Health Technol Assess Ser; 2010; 10(21):1-111. PubMed ID: 23074399
[TBL] [Abstract][Full Text] [Related]
23. Use of deamidated gliadin peptide antibodies to monitor diet compliance in childhood celiac disease.
Monzani A; Rapa A; Fonio P; Tognato E; Panigati L; Oderda G
J Pediatr Gastroenterol Nutr; 2011 Jul; 53(1):55-60. PubMed ID: 21694536
[TBL] [Abstract][Full Text] [Related]
24. Diagnostic efficacy of the ELISA test for the detection of deamidated anti-gliadin peptide antibodies in the diagnosis and monitoring of celiac disease.
Tonutti E; Visentini D; Picierno A; Bizzaro N; Villalta D; Tozzoli R; Kodermaz G; Carroccio A; Iacono G; Teresi S; La Chiusa SM; Brusca I
J Clin Lab Anal; 2009; 23(3):165-71. PubMed ID: 19455636
[TBL] [Abstract][Full Text] [Related]
25. [Significance of a method for determination of deamidated gliadin peptide in the diagnosis of celiac disease].
Sabelnikova EA; Parfenov AI; Krums LM; Gudkova RB; Sagynbaeva VE; Bykova SV
Ter Arkh; 2014; 86(2):39-43. PubMed ID: 24772506
[TBL] [Abstract][Full Text] [Related]
26. IgA antibodies against deamidated gliadin peptides in patients with chronic liver diseases.
Gatselis NK; Zachou K; Norman GL; Tzellas G; Speletas M; Gabeta S; Germenis A; Koukoulis GK; Dalekos GN
Clin Chim Acta; 2012 Oct; 413(19-20):1683-8. PubMed ID: 22643316
[TBL] [Abstract][Full Text] [Related]
27. Diagnostic performances of celiac disease serological tests among Saudi patients.
Sghiri R; Hassine HB; Almogren A; Shakoor Z; Alswayyed M
Saudi J Gastroenterol; 2023; 29(1):31-38. PubMed ID: 36571384
[TBL] [Abstract][Full Text] [Related]
28. Correlation analysis of celiac sprue tissue transglutaminase and deamidated gliadin IgG/IgA.
Marietta EV; Rashtak S; Murray JA
World J Gastroenterol; 2009 Feb; 15(7):845-8. PubMed ID: 19230045
[TBL] [Abstract][Full Text] [Related]
29. Serologic screening for celiac disease in children: a comparison between established assays and tests with deamidated gliadin-derived peptides plus conjugates for both IgA and IgG antibodies.
Aberg AK; Olcén P
APMIS; 2009 Nov; 117(11):808-13. PubMed ID: 19845531
[TBL] [Abstract][Full Text] [Related]
30. Diagnostic accuracy of coeliac serological tests: a prospective study.
Reeves GE; Squance ML; Duggan AE; Murugasu RR; Wilson RJ; Wong RC; Gibson RA; Steele RH; Pollock WK
Eur J Gastroenterol Hepatol; 2006 May; 18(5):493-501. PubMed ID: 16607143
[TBL] [Abstract][Full Text] [Related]
31. Serologic assay for diagnosis of celiac disease based on a patient-derived monoclonal antigliadin antibody.
Steinsbø Ø; Dørum S; Lundin KE; Sollid LM
Gastroenterology; 2015 Nov; 149(6):1530-1540.e3. PubMed ID: 26208894
[TBL] [Abstract][Full Text] [Related]
32. Deamidated gliadin peptide and tissue transglutaminase antibodies in children with coeliac disease: A correlation study.
Saadah OI; Alamri AM; Al-Mughales JA
Arab J Gastroenterol; 2020 Sep; 21(3):174-178. PubMed ID: 32732170
[TBL] [Abstract][Full Text] [Related]
33. AGA Clinical Practice Update on Diagnosis and Monitoring of Celiac Disease-Changing Utility of Serology and Histologic Measures: Expert Review.
Husby S; Murray JA; Katzka DA
Gastroenterology; 2019 Mar; 156(4):885-889. PubMed ID: 30578783
[TBL] [Abstract][Full Text] [Related]
34. Diagnostic accuracy of a novel point-of-care test for simultaneous detection of anti-transglutaminase IgA and anti-deamidated gliadin IgG antibodies.
Parrinello G; Da Re M; Grizzo F; Camelliti S; Cozzi M; Marinoni F; Villalta D
J Clin Lab Anal; 2024 Feb; 38(3):e25003. PubMed ID: 38291818
[TBL] [Abstract][Full Text] [Related]
35. Combining antibody tests and taking into account antibody levels improves serologic diagnosis of celiac disease.
Oyaert M; Vermeersch P; De Hertogh G; Hiele M; Vandeputte N; Hoffman I; Bossuyt X
Clin Chem Lab Med; 2015 Sep; 53(10):1537-46. PubMed ID: 25719330
[TBL] [Abstract][Full Text] [Related]
36. Resurrection of gliadin antibodies in coeliac disease. Deamidated gliadin peptide antibody test provides additional diagnostic benefit.
Kaukinen K; Collin P; Laurila K; Kaartinen T; Partanen J; Mäki M
Scand J Gastroenterol; 2007 Dec; 42(12):1428-33. PubMed ID: 17852878
[TBL] [Abstract][Full Text] [Related]
37. Office-Based Point of Care Testing (IgA/IgG-Deamidated Gliadin Peptide) for Celiac Disease.
Lau MS; Mooney PD; White WL; Rees MA; Wong SH; Hadjivassiliou M; Green PHR; Lebwohl B; Sanders DS
Am J Gastroenterol; 2018 Aug; 113(8):1238-1246. PubMed ID: 29915400
[TBL] [Abstract][Full Text] [Related]
38. Clinical evaluation of the BioPlex 2200 Celiac IgA and IgG Kits - a novel multiplex screen incorporating an integral check for IgA deficiency.
Holding S; Wilson F; Spradbery D
J Immunol Methods; 2014 Mar; 405():29-34. PubMed ID: 24424297
[TBL] [Abstract][Full Text] [Related]
39. Isolated positive deamidated gliadin peptide-IgG has limited diagnostic utility in coeliac disease.
Vootukuru N; Singh H; Giles E
J Paediatr Child Health; 2022 Sep; 58(9):1648-1652. PubMed ID: 35726522
[TBL] [Abstract][Full Text] [Related]
40. Serological diagnosis of celiac disease: comparative analysis of different strategies.
Vermeersch P; Geboes K; Mariën G; Hoffman I; Hiele M; Bossuyt X
Clin Chim Acta; 2012 Nov; 413(21-22):1761-7. PubMed ID: 22771970
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
